Evaluating of Existing VTE Risk Scales in Glioma Patients.
Simakova MariaKonstantin A PishchulovLukinov VitaliyVoynov NikitaBulaeva MariaMelnichnikova OlgaZhilenkova YuliaSavelyeva АnnaMoiseeva OlgaSamochernykh KonstantinPublished in: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis (2024)
The Caprini Risk Assessment Model, the IMPROVE Risk Score, the IMPROVED VTE Risk Score, and the Padua Prediction Score exhibit acceptable specificity and sensitivity for glioma patients. However, their low positive predictive ability, coupled with the complexity of interpretation, limits their utility in neurosurgical practice.